Is PFE Stock a Buy After 14% Rise Post Drug Pricing Deal With Trump?Zacks Investment Research • 10/03/25
These 3 Stocks Pay More Than 6%. Are Their Dividend Yields Too Good to Be True?The Motley Fool • 10/03/25
2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 in OctoberThe Motley Fool • 10/03/25
Pfizer Just Made a Landmark Drug Pricing Agreement with President Donald Trump. Is the Stock a Buy?The Motley Fool • 10/03/25
The drug price deal between Pfizer and the Trump administration was built on down-to-the-wire team negotiations, building on a relationship between CEO Albert Bourla and President TrumpWSJ • 10/03/25
Heard on the Street: Pfizer's accord on price cuts with President Trump clears a cloud over the whole pharma industryWSJ • 10/02/25
Pfizer Just Announced a Massive Deal with TrumpRx. Here's What Investors Need to KnowThe Motley Fool • 10/01/25
Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look AwayBenzinga • 10/01/25
Trump's pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakersCNBC • 10/01/25
Swiss pharma companies likely to follow Pfizer-U.S. price deal, says business lobbyReuters • 10/01/25
3 Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 9.5% -- Which Are No-Brainer Buys in OctoberThe Motley Fool • 10/01/25